{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:12:28Z","timestamp":1762866748381,"version":"build-2065373602"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.joms.2015.10.025","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T20:55:10Z","timestamp":1446843310000},"page":"945-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?"],"prefix":"10.1016","volume":"74","author":[{"given":"Kenneth E.","family":"Fleisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-0337","authenticated-orcid":false,"given":"Sabrina","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy A.","family":"Raad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent P.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir","family":"Ghesani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2869-4273","authenticated-orcid":false,"given":"King Chong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Amintavakoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malvin","family":"Janal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie P.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2015.10.025_bib1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"AAOMS position paper: Medication-related osteonecrosis of the jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib2","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.joms.2012.05.019","article-title":"Resective surgical approach shows a high performance in management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: A retrospective survey of 347 cases","volume":"70","author":"Graziani","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib3","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.joms.2008.09.028","article-title":"The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw","volume":"67","author":"Otto","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaw\u2014Characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2015.10.025_bib7","doi-asserted-by":"crossref","first-page":"18s","DOI":"10.1200\/jco.2010.28.18_suppl.lba4507","article-title":"A randomized phase III trial of denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer","volume":"28","author":"Fizazi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2015.10.025_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.joms.2011.08.011","article-title":"Osteonecrosis of the maxilla associated with cancer chemotherapy in patients wearing dentures","volume":"70","author":"Infante-Cossio","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joms.2011.02.104","article-title":"Osteonecrosis after administration of intravitreous bevacizumab","volume":"70","author":"Hopp","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijom.2010.04.054","article-title":"Clinical comparison of patients with osteonecrosis of the jaw, with and without a history of bisphosphonates administration","volume":"39","author":"Kos","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.14219\/jada.archive.2009.0280","article-title":"Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: A review","volume":"140","author":"Almazrooa","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2015.10.025_bib14","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.joms.2012.02.019","article-title":"Osteonecrosis of the jaws unrelated to bisphosphonate exposure: A series of 4 cases","volume":"70","author":"Baur","year":"2012","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","article-title":"The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy","volume":"8","author":"Kumar","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.joms.2015.10.025_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ctrv.2012.02.002","article-title":"Antiresorptive therapies in oncology and their effects on cancer progression","volume":"38","author":"Bundred","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.joms.2015.10.025_bib17","first-page":"354","article-title":"Summary of ASBMR Task Force on ONJ","volume":"7","author":"Burr","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.joms.2015.10.025_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1634\/theoncologist.2007-0159","article-title":"Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: A retrospective study","volume":"13","author":"Ibrahim","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2015.10.025_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.critrevonc.2007.07.005","article-title":"Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?","volume":"64","author":"Diel","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.joms.2015.10.025_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1345\/aph.1H521","article-title":"Bisphosphonate-induced osteonecrosis of the jaw","volume":"41","author":"Krueger","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.joms.2015.10.025_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1634\/theoncologist.2008-0091","article-title":"Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy","volume":"13","author":"Estilo","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2015.10.025_bib22","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","article-title":"Oral health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14219\/jada.archive.2008.0002","article-title":"Closing in on the puzzle of ONJ","volume":"139","author":"Glick","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2015.10.025_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.joms.2015.10.025_bib25","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine Position Paper","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2015.10.025_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1601-0825.2009.01581.x","article-title":"Dental management of patients at risk of osteochemonecrosis of the jaws: A critical review","volume":"15","author":"Fedele","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2015.10.025_bib27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.joms.2015.10.025_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2015.10.025_bib29","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.joms.2015.01.008","article-title":"Surgical therapy for bisphosphonate-related osteonecrosis of the jaw: Six-year experience of a single institution","volume":"73","author":"Lopes","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0b013e32819f820b","article-title":"Osteonecrosis of the jaw related to the use of bisphosphonates","volume":"19","author":"Van den Wyngaert","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.joms.2015.10.025_bib31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2146\/ajhp080251","article-title":"Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates","volume":"66","author":"Gebara","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.joms.2015.10.025_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijom.2009.11.014","article-title":"Surgical management of bisphosphonate induced osteonecrosis of the jaws","volume":"39","author":"Williamson","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2015.10.025_bib34","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014An initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma","volume":"69","author":"Curi","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2010.08.013","article-title":"Bisphosphonate-associated osteonecrosis of the jaws: Surgical treatment with ErCrYSGG-laser. Case report","volume":"110","author":"Rugani","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2015.10.025_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.joms.2010.07.014","article-title":"Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: First clinical results of a prospective study","volume":"69","author":"Pautke","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib37","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.joms.2015.10.025_bib38","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.joms.2006.07.012","article-title":"Treating bisphosphonate osteonecrosis of the jaws: Is there a role for resection and vascularized reconstruction?","volume":"65","author":"Engroff","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib40","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hed.20864","article-title":"Treatment results of bisphosphonate-related osteonecrosis of the jaws","volume":"30","author":"Wutzl","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2015.10.025_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joms.2008.12.057","article-title":"Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: Review of 33 surgical cases","volume":"67","author":"Stanton","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autogenous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2015.10.025_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.joms.2007.06.046","article-title":"Update on bisphosphonate-related osteonecrosis of the jaw treatment strategies and outcomes","volume":"65","author":"Carlson","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.joms.2007.11.025","article-title":"Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws","volume":"66","author":"Vescovi","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: Technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib48","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hed.21019","article-title":"Bisphosphonate-associated osteonecrosis of the jaws: The limits of a conservative approach","volume":"31","author":"Tirelli","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2015.10.025_bib49","first-page":"2313","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: A challenging problem","volume":"31","author":"Eckardt","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.joms.2015.10.025_bib50","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.joms.2014.05.010","article-title":"Response to the letter to the editor","volume":"72","author":"Carlson","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib51","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.joms.2014.05.009","article-title":"Re: Management of antiresorptive osteonecrosis of the jaws with primary surgical resection","volume":"72","author":"Schwartz","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib52","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.joms.2008.11.015","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A single-center study of 101 patients","volume":"67","author":"Lazarovici","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.oraloncology.2011.02.024","article-title":"Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis","volume":"47","author":"Bedogni","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2015.10.025_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2009.01.011","article-title":"Bisphosphonates\u2014What the dentist needs to know: Practical considerations","volume":"67","author":"Fantasia","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib55","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: Bone scintigraphy as an early indicator","volume":"67","author":"O'Ryan","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib56","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3174\/ajnr.A3355","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: Comparison of disease extent on contrast-enhanced MR imaging, [18F] fluoride PET\/CT, and cone-beam CT imaging","volume":"34","author":"Guggenberger","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.joms.2015.10.025_bib57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00006231-200608000-00006","article-title":"Nuclear medicine imaging of bone infections","volume":"27","author":"Prandini","year":"2005","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.joms.2015.10.025_bib58","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2106\/00004623-200105000-00002","article-title":"Fluorine-18 fluorodeoxyglucose-positron emission tomography: A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections","volume":"83","author":"De Winter","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.joms.2015.10.025_bib59","first-page":"2464","article-title":"The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: A systematic review and meta-analysis","volume":"87","author":"Termaat","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.joms.2015.10.025_bib60","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.joms.2014.04.017","article-title":"Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw","volume":"72","author":"Fleisher","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib61","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2015.10.025_bib62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: A correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2015.10.025_bib63","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1601-0825.2005.01130.x","article-title":"Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy","volume":"11","author":"Pires","year":"2005","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2015.10.025_bib64","first-page":"12","article-title":"Detection of musculoskeletal infection with 18F-FDG PET: Review of the current literature","volume":"32","author":"Crymes","year":"2004","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.joms.2015.10.025_bib65","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijom.2006.03.029","article-title":"The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible","volume":"35","author":"Hakim","year":"2006","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib66","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.joms.2010.05.003","article-title":"Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure","volume":"68","author":"Hutchinson","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s000110050193","article-title":"A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis","volume":"46","author":"Golub","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.joms.2015.10.025_bib68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.coms.2007.07.001","article-title":"Contemporary concepts in the treatment of chronic osteomyelitis","volume":"19","author":"Coviello","year":"2007","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.joms.2015.10.025_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.coms.2014.01.005","article-title":"Anti-resorptive osteonecrosis of the jaws: Facts forgotten, questions answered, lessons learned","volume":"26","author":"Carlson","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.joms.2015.10.025_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.joms.2008.12.003","article-title":"Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Freiberger","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib71","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: A randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib72","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0300-9785(84)80063-0","article-title":"Hyperbaric oxygen treatment of chronic osteomyelitis of the jaws","volume":"13","author":"Van Merkestyn","year":"1984","journal-title":"Int J Oral Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib73","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0278-2391(82)90113-6","article-title":"Experimental mandibular osteomyelitis: Therapeutic trials with hyperbaric oxygen","volume":"40","author":"Tripplett","year":"1982","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1097-0347(199808)20:5<411::AID-HED9>3.0.CO;2-0","article-title":"A modified protocol for early treatment of osteomyelitis and osteoradionecrosis of the mandible","volume":"20","author":"Aitasalo","year":"1998","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2015.10.025_bib75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bjoms.2014.12.004","article-title":"Sclerosis in bisphosphonate-related osteonecrosis of the jaws and its correlation with the clinical stages: Study of 43 cases","volume":"53","author":"Bagan","year":"2015","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib76","first-page":"1241","article-title":"Hyperbaric oxygen therapy accelerates vascularization in keratinized oral mucosal surgical flaps","volume":"36","author":"Helmers","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2015.10.025_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.0906-6713.2002.03312.x","article-title":"Radiotherapy, osseointegration and hyperbaric oxygen therapy","volume":"33","author":"Granstrom","year":"2000","journal-title":"Periodontology"},{"key":"10.1016\/j.joms.2015.10.025_bib78","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.joms.2006.01.012","article-title":"Placement of dental implants in irradiated bone: The case for using hyperbaric oxygen","volume":"64","author":"Granstrom","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib79","first-page":"699","article-title":"A histomorphometric study of bone reactions to titanium implants in irradiated bone and the effect of hyperbaric oxygen treatment","volume":"14","author":"Johnsson","year":"1999","journal-title":"Int J Oral Maxillofac Implants"},{"key":"10.1016\/j.joms.2015.10.025_bib80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.coms.2012.10.002","article-title":"Emerging concepts in the management and treatment of osteonecrosis of the jaw","volume":"25","author":"Ruggiero","year":"2013","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.joms.2015.10.025_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1601-0825.2008.01494.x","article-title":"Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws","volume":"15","author":"Treister","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.joms.2015.10.025_bib82","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0030-4220(75)90240-6","article-title":"Comment on reactive hyperplasia of bone","volume":"40","author":"Alling","year":"1975","journal-title":"Oral Surg Oral Med Oral Pathol"},{"year":"2009","series-title":"Oral and Maxillofacial Pathology","author":"Neville","key":"10.1016\/j.joms.2015.10.025_bib83"},{"key":"10.1016\/j.joms.2015.10.025_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1042-3699(02)00073-0","article-title":"Diagnosis and treatment of diffuse sclerosing osteomyelitis of the jaws","volume":"15","author":"Montonen","year":"2003","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.joms.2015.10.025_bib85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmbbm.2012.09.002","article-title":"Localized sclerotic bone response demonstrated reduced nanomechanical creep properties","volume":"17","author":"Chen","year":"2013","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.joms.2015.10.025_bib86","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/02841850510021788","article-title":"Reactive sclerosis: Hyperintense appearance on T2-weighted magnetic resonance imaging","volume":"5","author":"Kanberoglu","year":"2005","journal-title":"Acta Radiol"},{"key":"10.1016\/j.joms.2015.10.025_bib87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.joms.2015.10.025_bib88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.moo.0000124936.46948.6a","article-title":"The role of biofilms in otolaryngologic infections","volume":"12","author":"Post","year":"2004","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib89","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bdj.2010.927","article-title":"Osteomyelitis presenting in two patients: A challenging disease to manage","volume":"209","author":"Patel","year":"2010","journal-title":"Br Dent J"},{"year":"2005","series-title":"Rubin's Pathology: Clinicopathologic Foundations of Medicine","author":"Rubin","key":"10.1016\/j.joms.2015.10.025_bib90"},{"key":"10.1016\/j.joms.2015.10.025_bib91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.joms.2009.07.086","article-title":"Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?","volume":"68","author":"Yarom","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","article-title":"Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: A pooled case report analysis","volume":"73","author":"Hinson","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib93","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.joms.2015.10.025_bib94","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2015.10.025_bib95","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tripleo.2010.04.023","article-title":"Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers","volume":"110","author":"Fleisher","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2015.10.025_bib96","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hed.21708","article-title":"Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"34","author":"Wutzl","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2015.10.025_bib97","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2012.07.008","article-title":"Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs)","volume":"49","author":"Holzinger","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.joms.2015.10.025_bib98","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","article-title":"Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction","volume":"68","author":"Saia","year":"2010","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239115014354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239115014354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:50:01Z","timestamp":1759510201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239115014354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0278239115014354"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2015.10.025","relation":{},"ISSN":["0278-2391"],"issn-type":[{"type":"print","value":"0278-2391"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2015.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}